Skip to main content
Livermore
Livermore
ZHEN

Private Advisor Group, LLC

SEC CIK
0001567755
Latest filing
Jul 27, 2026

PACB holding history

Pacific Biosciences of California, Inc. in every 13F filed by Private Advisor Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PACB overviewAll 13F holders of PACBFull Q2 2026 holdings

Shares (Q2 2026)
17,237
Value
$29.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PACB by Private Advisor Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,237$29.0K<0.1%−7,500−30.3%ReducedHolders
Q1 202624,737$32.7K<0.1%+441+1.8%AddedHolders
Q4 202524,296$45.4K<0.1%−4,323−15.1%ReducedHolders
Q3 202528,619$36.6K<0.1%−1,150−3.9%ReducedHolders
Q2 202529,769$36.9K<0.1%+6,386+27.3%AddedHolders
Q1 202523,383$27.6K<0.1%−2,625−10.1%ReducedHolders
Q4 202426,008$47.6K<0.1%−1,853−6.7%ReducedHolders
Q3 202427,861$47.4K<0.1%+143+0.5%AddedHolders
Q2 202427,718$38.0K<0.1%+2,385+9.4%AddedHolders
Q1 202425,333$95.0K<0.1%+5,942+30.6%AddedHolders
Q4 202319,391$190.2K<0.1%−349−1.8%ReducedHolders
Q3 202319,740$164.8K<0.1%+2,027+11.4%AddedHolders
Q2 202317,713$235.6K<0.1%+4,402+33.1%AddedHolders
Q1 202313,311$154.1K<0.1%+500+3.9%AddedHolders
Q4 202212,811$105<0.1%−900−6.6%ReducedHolders
Q3 202213,711$80.0K<0.1%−1,458−9.6%ReducedHolders
Q2 202215,169$67.0K<0.1%−4,377−22.4%ReducedHolders
Q1 202219,546$178.0K<0.1%+59+0.3%AddedHolders
Q4 202119,487$399.0K<0.1%+3,300+20.4%AddedHolders
Q3 202116,187$414.0K<0.1%−400−2.4%ReducedHolders
Q2 202116,587$580.0K<0.1%−851−4.9%ReducedHolders
Q1 202117,438$581.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.